Fortis Group Advisors, LLC

Position in PGEN — Precigen, Inc.

CIK 1815183 WESTWOOD, NJ

Position in PGEN

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$108,106

+$34,708 QoQ

Shares Held

18,966

0.0% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#150

of 210 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Fortis Group Advisors, LLC holds $498,707 across 4 Biotechnology names. PGEN ranks #3 (21.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	1,105	$270,470
2	LXRX	Lexicon Pharmaceuticals, Inc.	50,000	$120,000
3	PGEN	Precigen, Inc. This page	18,966	$108,106
4	CRBP	Corbus Pharmaceuticals Holdings, Inc.	14	$131

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$108,106	18,966	0.0%	Shares	Sole	2026-07-24
2026-03-31	$73,398	18,966	0.0%	Shares	Sole	2026-05-08
2025-12-31	$79,277	18,966	0.0%	Shares	Sole	2026-02-06
2025-09-30	$62,398	18,966	0.0%	Shares	Sole	2025-11-07
2025-06-30	$26,931	18,966	0.0%	Shares	Sole	2025-08-08
2025-03-31	$28,259	18,966	0.0%	Shares	Sole	2025-05-02
2024-12-31	$21,241	18,966	0.0%	Shares	Sole	2025-01-31
2024-09-30	$18,017	18,966	0.0%	Shares	Sole	2024-10-21
2024-06-30	$29,966	18,966	0.0%	Shares	Sole	2024-07-30
2024-03-31	$27,500	18,966	—	Shares	Sole	2024-04-30
No filing history on record for this holder in this stock.